"The Effect of Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19"
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study; to examine the effects of aerobic and strength training on physical activity level, quality of life and anxiety-stress disorder in young adults with and without COVID-19. In this context, the study was planned by including 15 participants between the ages of 18-25 who had COVID-19 and 15 who did not have COVID-19. Data were collected by applying the Personal Data Form, IPAQ (International Physical Activity Form), SF-36 Quality of Life Scale, Coronavirus Anxiety Scale (CCS), Respiratory Function Tests (PFT), Six Minute Walk Test (6MWT). Aerobic training and strengthening training were applied to people with and without COVID-19 for 12 weeks. Aerobic exercise (walking) was given for 40 minutes 5 days a week, with the target heart rate being 70% of the age-corrected maximum heart rate. Strengthening exercises were applied to the upper (triceps, biceps, deltoid, pectorals) and lower (quadriceps, hamstring, gastrocnemius, tibialis anterior, hip adductors, hip flexors, hip extensors) extremities and back muscles (trapezius, latissimus dorsi) with theraband (resistance band). Significance test of the difference between two means in comparing independent group differences when parametric test assumptions are met for statistical analysis in line with the data collected from the participants; When parametric test assumptions are not met, Mann Whitney U test is used to compare independent group differences, while when parametric test assumptions are met to examine dependent group differences, the significance test of the difference between the two spouses is used; When parametric test assumptions were not met, the Wilcoxon paired two sample test was used. In all analyses, p \< .05 was considered statistically significant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable covid19
Started Feb 2022
Longer than P75 for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2023
CompletedFirst Submitted
Initial submission to the registry
November 22, 2023
CompletedFirst Posted
Study publicly available on registry
November 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2024
CompletedJanuary 24, 2025
January 1, 2025
1.2 years
November 22, 2023
January 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
International Physical Activity Questionnaire
Used to define participants physical activity level
5 minute
SF-36
Used to indicate the health status of participants
10 minute
Coronavirus Anxiety Scale
Used to evaluate experience some psychological problems such as anxiety and depression depends on COVID-19
1 minute
Respiratory Function Tests
Used to evaluation of the respiratory system
5 minute
The 6 Minute Walk Test
Used to assess aerobic capacity and endurance
6 minute
Study Arms (2)
COVID-19 positive
EXPERIMENTALCOVID-19 negative
EXPERIMENTALInterventions
Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19
Eligibility Criteria
You may qualify if:
- Volunteering to participate in the study,
- Able to communicate, without hearing and/or visual impairment,
- Being between the ages of 18-25
- Not having a systemic disease
- Having had COVID-19 in the last 6 months to be included in the study group
You may not qualify if:
- Unable to communicate, hearing and/or visually impaired,
- Not being between the ages of 18-25
- Having a systemic disease other than COVID-19 infection,
- Having had COVID-19 more than 6 months ago.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Aydin University
Istanbul, Kücükcekmece, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
November 22, 2023
First Posted
November 24, 2023
Study Start
February 21, 2022
Primary Completion
April 21, 2023
Study Completion
December 19, 2024
Last Updated
January 24, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
If there is a reasonable request.